Use of recombinant human bone morphogenetic protein-2 in the treatment of degenerative spondylolisthesis

Gregory D. Schroeder*, Wellington K. Hsu, Christopher K. Kepler, Mark F. Kurd, Alexander R. Vaccaro, Alpesh A. Patel, Jason W. Savage

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Use of recombinant human bone morphogenetic protein-2 in the treatment of degenerative spondylolisthesis'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science